HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RARalpha.

Abstract
PML-RARalpha is the causative oncogene in 5% to 10% of the cases of acute myeloid leukemia. At physiological concentrations of retinoic acid, PML-RARalpha silences RARalpha target genes, blocking differentiation of the cells. At high concentrations of ligand, it (re)activates the transcription of target genes, forcing terminal differentiation. The study of RARalpha target genes that mediate this differentiation has identified several genes that are important for proliferation and differentiation control in normal and malignant hematopoietic cells. In this paper, we show that the PML-RARalpha fusion protein not only interferes with the transcription of regular RARalpha target genes. We show that the ID1 and ID2 promoters are activated by PML-RARalpha but, unexpectedly, not by wild-type RARalpha/RXR. Our data support a model in which the PML-RARalpha fusion protein regulates a novel class of target genes by interaction with the Sp1 and NF-Y transcription factors, without directly binding to the DNA, defining a gain-of-function for the oncoprotein.
AuthorsSake van Wageningen, Marleen C Breems-de Ridder, Jeannet Nigten, Gorica Nikoloski, Claudia A J Erpelinck-Verschueren, Bob Löwenberg, Theo de Witte, Daniel G Tenen, Bert A van der Reijden, Joop H Jansen
JournalBlood (Blood) Vol. 111 Issue 3 Pg. 1634-43 (Feb 01 2008) ISSN: 0006-4971 [Print] United States
PMID18025157 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CCAAT-Binding Factor
  • ID1 protein, human
  • Inhibitor of Differentiation Protein 1
  • Oncogene Proteins, Fusion
  • RARA protein, human
  • Receptors, Retinoic Acid
  • Retinoic Acid Receptor alpha
  • Retinoid X Receptors
  • Sp1 Transcription Factor
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
  • Tretinoin
  • DNA
Topics
  • CCAAT-Binding Factor (genetics, metabolism)
  • Cell Line, Tumor
  • DNA (genetics, metabolism)
  • Humans
  • Inhibitor of Differentiation Protein 1 (genetics, metabolism)
  • Leukemia, Promyelocytic, Acute (genetics, pathology)
  • Molecular Sequence Data
  • Oncogene Proteins, Fusion (genetics, metabolism)
  • Promoter Regions, Genetic (genetics)
  • Protein Binding
  • Receptors, Retinoic Acid (genetics, metabolism)
  • Retinoic Acid Receptor alpha
  • Retinoid X Receptors (genetics, metabolism)
  • Sp1 Transcription Factor (genetics, metabolism)
  • Transcriptional Activation (drug effects, genetics)
  • Tretinoin (pharmacology)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: